<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 7, 1994
REGISTRATION NO. 33-53957
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
POST-EFFECTIVE
AMENDMENT NO. 1
TO
FORM S-4
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
CORAM HEALTHCARE CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<TABLE>
<S> <C> <C>
DELAWARE 8082 33-0615337
(STATE OR OTHER JURISDICTION OF (PRIMARY STANDARD INDUSTRIAL (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) CLASSIFICATION CODE NUMBER) IDENTIFICATION NUMBER)
</TABLE>
ONE LAKESHORE CENTRE
3281 GUASTI ROAD, SUITE 700
ONTARIO, CALIFORNIA 91761
(909) 460-2400
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER,
INCLUDING AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
------------------------
KEVIN M. HIGGINS, ESQ.
ONE LAKESHORE CENTRE
3281 GUASTI ROAD, SUITE 700
ONTARIO, CALIFORNIA 91761
(909) 460-2400
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF AGENT FOR SERVICE)
------------------------
COPIES TO:
<TABLE>
<S> <C> <C> <C>
R.M. MATTSON, JR., ESQ. B.E. MACDONOUGH, ESQ. M.A. KIMBALL, ESQ. R.A. FINK, ESQ.
T.S. POWELL, ESQ. R.R. ORAND, ESQ. C.J. MCLAUGHLIN, ESQ. K.M. CLAYTON, ESQ.
MORRISON & FOERSTER GREENBERG, TRAURIG, OPPENHEIMER WOLFF & BROBECK, PHLEGER &
19900 MACARTHUR BLVD. HOFFMAN, LIPOFF, ROSEN & DONNELLY HARRISON
IRVINE, CA 92715 QUENTEL, P.A. 45 SOUTH SEVENTH ST. 4675 MACARTHUR COURT,
1221 BRICKELL AVENUE MINNEAPOLIS, MN 55402 SUITE 1000
MIAMI, FL 33131 NEWPORT BEACH, CA 92660
</TABLE>
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
AS SOON AS PRACTICABLE AFTER THIS REGISTRATION STATEMENT BECOMES EFFECTIVE.
------------------------
If the securities being registered on this form are being offered in
compliance with General Instruction G, check the following box: / /
------------------------
The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 20. INDEMNIFICATION OF DIRECTORS AND OFFICERS
(a) As permitted by the Delaware General Corporation Law, CHM Holding's
Certificate of Incorporation (the "CHM Holding Certificate") eliminates the
liability of directors to CHM Holding or its stockholders for monetary damages
for breach of fiduciary duty as a director, except to the extent otherwise
required by the Delaware General Corporation Law.
(b) The CHM Holding Bylaws provide that CHM Holding will indemnify each
person who was or is made a party to any proceeding by reason of the fact that
such person is or was a director, officer, employee or agent of CHM Holding
against all expense, liability and loss reasonably incurred or suffered by such
person in connection therewith to the fullest extent authorized by the Delaware
General Corporation Law.
ITEM 21. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(A) EXHIBITS.
The exhibits to the Registration Statement required by Item 601 of
Regulation S-K are listed in the accompanying index to exhibits.
(B) FINANCIAL STATEMENTS AND SCHEDULES.
(1) Financial Statements
The financial statements filed as part of this Registration Statement are
indexed for each of Curaflex, HealthInfusion and Medisys on Page F-1.
(2) Schedules
The following financial statement schedules of each of Curaflex,
HealthInfusion and Medisys are included in this Form S-4:
(a) Curaflex Health Services, Inc. and Subsidiaries:
<TABLE>
<CAPTION>
SCHEDULE NO. PAGE NO. DESCRIPTION OF SCHEDULE
- ----------------- -------- ----------------------------------------------------
<S> <C> <C>
Not applicable S-1 Independent Auditor's Report
Schedule II S-2 Amounts Receivable From Related Parties and
Underwriters, Promoters, and Employees Other Than
Related Parties
Schedule VIII S-3 Valuation and Qualifying Accounts
Schedule X S-4 Supplementary Income Statement Information For the
Years Ended December 31, 1991, 1992 and 1993
</TABLE>
(b) HealthInfusion, Inc. and Subsidiaries:
<TABLE>
<CAPTION>
SCHEDULE NO. PAGE NO. DESCRIPTION OF SCHEDULE
- ----------------- -------- ----------------------------------------------------
<S> <C> <C>
Not applicable S-5 Independent Auditor's Report
Schedule II S-6 Amounts Receivable From Related Parties
Schedule VIII S-7 Valuation and Qualifying Accounts
Schedule IX S-8 Short-Term Borrowings
Schedule X S-9 Supplementary Income Statement Information For the
Years Ended December 31, 1991, 1992 and 1993
</TABLE>
II-1
<PAGE> 3
(c) Medisys, Inc. and Subsidiaries:
<TABLE>
<CAPTION>
SCHEDULE NO. PAGE NO. DESCRIPTION OF SCHEDULE
- ----------------- -------- ----------------------------------------------------
<S> <C> <C>
Not applicable S-10 Independent Auditors' Report
Schedule VIII S-11 Valuation and Qualifying Accounts and Reserves For
the Years Ended December 31, 1991, 1992 and 1993
Schedule IX S-12 Short-Term Borrowings For the Years Ended December
31, 1991, 1992 and 1993
Schedule X S-13 Supplementary Income Statement Information For the
Years Ended December 31, 1991, 1992 and 1993
</TABLE>
Schedules other than those listed above have been omitted because they
either are not required, are not applicable or the information is included in
the appropriate financial statements and notes thereto.
(C) OPINIONS OF FINANCIAL ADVISORS.
(1) The opinion of Smith Barney Inc. constitutes Appendix C to the
Joint Proxy Statement/ Prospectus.
(2) The opinion of Hambrecht & Quist constitutes Appendix D to the
Joint Proxy Statement/ Prospectus.
(3) The opinion of Piper Jaffray Inc. constitutes Appendix E to the
Joint Proxy Statement/ Prospectus.
(4) The opinion of Kidder, Peabody & Co. Incorporated constitutes
Appendix F to the Joint Proxy Statement/Prospectus.
ITEM 22. UNDERTAKINGS
The undersigned Registrant hereby undertakes that:
(a)(1) The undersigned registrant hereby undertakes as follows: that
prior to any public reoffering of the securities registered hereunder
through use of a prospectus which is part of this registration statement,
by any person or party who is deemed to be an underwriter within the
meaning of Rule 145(c), the issuer undertakes that such reoffering
prospectus will contain the information called for by the applicable
registration form with respect to reofferings by persons who may be deemed
underwriters, in addition to the information called for by the other items
of the applicable form.
(2) The registration undertakes that every prospectus: (i) that is
filed pursuant to paragraph (1) immediately preceding, or (ii) that
purports to met the requirements of Section 10(a)(3) of the Act and is
used in connection with an offering of securities subject to Rule 415,
will be filed as a part of an amendment to the registration statement
and will not be used until such amendment is effective, and that, for
purposes of determining any liability under the Securities Act of 1933,
each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
(b) The undersigned registrant hereby undertakes to respond to
requests for information that is incorporated by reference into the
prospectus pursuant to Item 4, 10(b), 11, or 13 of this form, within one
business day of receipt of such request, and to send the incorporated
documents by first class mail or other equally prompt means. This includes
information contained in documents filed subsequent to the effective date
of the registration statement through the date of responding to the
request.
(c) The undersigned registrant hereby undertakes to supply by means of
a post-effective amendment all information concerning a transaction, and
the company being acquired involved therein, that was not the subject of
and included in the registration statement when it became effective.
II-2
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this Post-Effective Amendment No. 1 to the Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Newport Beach, California, on this 6th day of June, 1994.
CORAM HEALTHCARE CORPORATION
By: /s/ JAMES M. SWEENEY
James M. Sweeney,
Chief Executive Officer and
Chairman
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed
below by the following persons in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
SIGNATURES TITLE DATE
- ------------------------------------------ ------------------------------- ------------------
<C> <S> <C>
/s/ JAMES M. SWEENEY Chief Executive Officer June 6, 1994
James M. Sweeney and Chairman
(Principal Executive Officer)
*/s/ NORMAN H. WERTHWEIN Acting Chief Financial Officer June 6, 1994
Norman H. Werthwein (Acting Principal Financial and
Accounting Officer)
*/s/ CHARLES A. LAVERTY Senior Executive Vice President June 6, 1994
Charles A. Laverty
*/s/ TOMMY H. CARTER Vice Chairman of the Board June 6, 1994
Tommy H. Carter
*/s/ MILES E. GILMAN Director June 6, 1994
Miles E. Gilman
*/s/ L. PETER SMITH Director June 6, 1994
L. Peter Smith
*/s/ RICHARD A. FINK Director June 6, 1994
Richard A. Fink
*/s/ STEPHEN G. PAGLIUCA Director June 6, 1994
Stephen G. Pagliuca
*By /s/ JAMES M. SWEENEY
James M. Sweeney
(Attorney-in-fact)
</TABLE>
II-3
<PAGE> 5
INDEPENDENT AUDITORS' REPORT ON SCHEDULES
The Board of Directors
Curaflex Health Services, Inc.
The audits referred to in our report dated February 28, 1994 included the
related financial statement schedules as of December 31, 1993 and for each of
the years in the three year period ended December 31, 1993, included in the
registration statement. These financial statement schedules are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statement schedules based on our audits. In our
opinion, such financial statement schedules, when considered in relation to the
basic consolidated financial statements taken as a whole, present fairly in all
material respects the information set forth therein.
KPMG Peat Marwick
Ontario, California
February 28, 1994
S-1
<PAGE> 6
SCHEDULE II
CURAFLEX HEALTH SERVICES, INC. AND SUBSIDIARIES
AMOUNTS RECEIVABLE FROM RELATED PARTIES AND UNDERWRITERS,
PROMOTERS, AND EMPLOYEES OTHER THAN RELATED PARTIES
(IN THOUSANDS)
<TABLE>
<CAPTION>
BALANCE
DEDUCTIONS AT END OF PERIOD
BALANCE AT ------------------------- -------------------
BEGINNING OF AMOUNTS AMOUNTS NOT
NAME OF DEBTOR PERIOD ADDITIONS COLLECTED WRITTEN OFF CURRENT CURRENT
- ---------------------------------- ------------ --------- --------- ----------- ------- -------
<S> <C> <C> <C> <C> <C> <C>
Charles A. Laverty(1)
Year ended December 31, 1992 $ -- $ 400 $ -- $ -- $ 400 $ --
Year ended December 31, 1993 400 17 -- -- 417 --
Irwin Kramer(2)
Year ended December 31, 1991 78 77 -- -- -- 155
Year ended December 31, 1992 155 77 -- -- -- 232
Year ended December 31, 1993 232 77 -- -- -- 309
</TABLE>
- ---------------
(1) Principal amount and all interest accumulated thereon at an interest rate of
3.61% per annum, is due in one payment on November 1, 1994. This note is
non-collateralized.
(2) Interest receivable relates to an $860 thousand stock purchase note and is
due December 31, 1999.
S-2
<PAGE> 7
SECTION VIII
CURAFLEX HEALTH SERVICES, INC. AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS
(IN THOUSANDS)
<TABLE>
<CAPTION>
CONTRACTUAL BALANCE
BALANCE AT ADDITIONS CHARGED TO ALLOWANCE AT END
BEGINNING FROM BUSINESS COSTS/ CHARGED TO OF
DESCRIPTION OF PERIOD COMBINATIONS EXPENSES REVENUES DEDUCTIONS(1) PERIOD
- ------------------------------- ---------- ------------- ---------- ----------- ------------ -------
<S> <C> <C> <C> <C> <C> <C>
Allowance for doubtful accounts
and contractual adjustments:
Year ended December 31, 1991... $ 5,118 $ -- $3,618 $ 7,951 $ (8,149) $ 8,538
---------- ------------- ---------- ----------- ------------ -------
---------- ------------- ---------- ----------- ------------ -------
Year ended December 31, 1992... $ 8,538 $ 1,181 $5,679 $12,328 $(20,658) $ 7,068
---------- ------------- ---------- ----------- ------------ -------
---------- ------------- ---------- ----------- ------------ -------
Year ended December 31, 1993... $ 7,068 $ 2,834 $5,557 $40,380 $(40,475) $15,364
---------- ------------- ---------- ----------- ------------ -------
---------- ------------- ---------- ----------- ------------ -------
</TABLE>
- ---------------
(1) Amounts reflect write-off of amounts that are deemed uncollectible.
S-3
<PAGE> 8
SCHEDULE X
CURAFLEX HEALTH SERVICES, INC. AND SUBSIDIARIES
SUPPLEMENTARY INCOME STATEMENT INFORMATION
FOR THE YEARS ENDED DECEMBER 31, 1991, 1992 AND 1993
(IN THOUSANDS)
<TABLE>
<CAPTION>
CHARGED TO COSTS AND
EXPENSES
--------------------------
ITEM 1991 1992 1993
- ------------------------------------------------------------------- ---- ------ ------
<S> <C> <C> <C>
Maintenance and repairs............................................ -- -- --
Depreciation....................................................... $903 $1,162 $2,022
Amortization of goodwill........................................... 58 315 1,362
Amortization of organization and pre-startup costs................. -- 135 614
Amortization of patent............................................. -- -- 3
---- ------ ------
Total depreciation and amortization of intangible assets,
preoperating costs and similar deferrals............... $961 $1,612 $4,001
---- ------ ------
---- ------ ------
Taxes other than payroll and income taxes.......................... -- -- --
Royalties.......................................................... -- -- --
Advertising costs.................................................. -- -- --
</TABLE>
S-4
<PAGE> 9
REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
ON SCHEDULES
To the Stockholders of
HealthInfusion, Inc. and subsidiaries:
We have audited in accordance with generally accepted auditing standards,
the consolidated financial statements of HealthInfusion, Inc. and subsidiaries
included in this joint proxy statement/prospectus, and have issued our report
thereon dated March 18, 1994. Our audits were made for the purpose of forming an
opinion on those financial statements taken as a whole. The schedules included
are the responsibility of the Company's management and are presented for
purposes of complying with the Securities and Exchange Commission's rules and
are not part of the basic financial statements. These schedules have been
subjected to the auditing procedures applied in the audits of the basic
financial statements and, in our opinion, fairly state in all material respects
the financial data required to be set forth therein in relation to the basic
financial statements taken as a whole.
ARTHUR ANDERSEN & CO.
Miami, Florida,
March 18, 1994.
S-5
<PAGE> 10
SCHEDULE II
HEALTHINFUSION, INC. AND SUBSIDIARIES
AMOUNTS RECEIVABLE FROM RELATED PARTIES
<TABLE>
<CAPTION>
DEDUCTIONS BALANCE AT END
BALANCE AT ------------------------ OF PERIOD
BEGINNING AMOUNTS AMOUNTS ---------------------
NAME OF DEBTOR OF PERIOD ADDITIONS COLLECTED WRITTEN OFF CURRENT NOT CURRENT
- ----------------------------------- ---------- -------- ---------- ----------- ------- -----------
<S> <C> <C> <C> <C> <C> <C>
Year ended December 31, 1993
Brian Dickson.................... $ -- $444,000 $ -- $ -- $ -- $ 444,000
</TABLE>
S-6
<PAGE> 11
SCHEDULE VIII
HEALTHINFUSION, INC. AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS
<TABLE>
<CAPTION>
BALANCE
BALANCE AT PROVISION FOR AT
BEGINNING DOUBTFUL ACCOUNTS END OF
OF PERIOD ACCOUNTS OTHER WRITTEN OFF PERIOD
---------- ------------- ------- ----------- ----------
<S> <C> <C> <C> <C> <C>
Allowance for contractual adjustments and
doubtful accounts
For the Year Ended December 31, 1991....... $ 557,267 $ 548,453 $ -- $ (256,255) $ 849,465
---------- ------------- ------- ----------- ----------
---------- ------------- ------- ----------- ----------
For the Year Ended December 31, 1992....... $ 849,465 $ 1,205,399 $ -- $ (399,558) $1,655,306
---------- ------------- ------- ----------- ----------
---------- ------------- ------- ----------- ----------
For the Year Ended December 31, 1993....... $1,655,306 $ 5,658,519 $ -- $(3,614,443) $3,699,382
---------- ------------- ------- ----------- ----------
---------- ------------- ------- ----------- ----------
</TABLE>
S-7
<PAGE> 12
SCHEDULE IX
HEALTHINFUSION, INC. AND SUBSIDIARIES
SHORT-TERM BORROWINGS
<TABLE>
<CAPTION>
MAXIMUM AVERAGE WEIGHTED
CATEGORY OF WEIGHTED AMOUNT AMOUNT AVERAGE
AGGREGATE BALANCE AVERAGE OUTSTANDING OUTSTANDING INTEREST RATE
SHORT-TERM AT END INTEREST DURING THE DURING THE DURING THE
BORROWINGS OF PERIOD RATE PERIOD PERIOD PERIOD
- ----------------------------------- ----------- ---------- ------------- ------------- ---------------
<S> <C> <C> <C> <C> <C>
For the Year Ended December 31,
1991............................. No short-term borrowings during the year ended December 31, 1991
For the Year Ended December 31,
1992
Bank borrowings.................. $ 4,537,887 6.25% $ 4,916,636 $ 3,788,253 6.20%
----------- ---------- ------------- ------------- -------
----------- ---------- ------------- ------------- -------
For the Year Ended December 31,
1993
Bank borrowings.................. $10,123,382 4.85% $ 11,113,377 $ 6,679,370 5.84%
----------- ---------- ------------- ------------- -------
----------- ---------- ------------- ------------- -------
</TABLE>
S-8
<PAGE> 13
SCHEDULE X
HEALTHINFUSION, INC. AND SUBSIDIARIES
SUPPLEMENTARY INCOME STATEMENT INFORMATION
FOR THE YEARS ENDED DECEMBER 31, 1991, 1992 AND 1993
<TABLE>
<CAPTION>
CHARGED TO COSTS AND EXPENSES
-------------------------------------
ITEM 1991 1992 1993
- ---------------------------------------------------------- -------- --------- -----------
<S> <C> <C> <C>
Goodwill amortization..................................... $295,984 $ 758,026 $ 1,052,016
Branch start-up costs..................................... 58,237 49,002 85,705
Other deferrals........................................... 34,604 57,510 129,967
-------- --------- -----------
Total amortization of assets, preoperating costs
and similar deferrals......................... $388,825 $ 864,538 $ 1,267,688
-------- --------- -----------
-------- --------- -----------
Advertising costs......................................... $296,412 $ 630,327 $ 875,924
-------- --------- -----------
-------- --------- -----------
</TABLE>
S-9
<PAGE> 14
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
To the Shareholders and Board of Directors of
Medisys, Inc.
In connection with our audit of the consolidated financial statements of
Medisys, Inc. as of December 31, 1993 and 1992 and for the years then ended,
which financial statements are included in the T2/Curaflex/
HealthInfusion/Medisys Registration Statement on Form S-4, we have also audited
the Medisys, Inc. supplemental financial statement schedules included herein.
The financial statements and financial statement schedules have been
restated to give retroactive effect to the merger of Medisys, Inc. and
Subsidiaries and American Home Therapies, Inc., on July 30, 1993, which has been
accounted for as a pooling of interests as described in Notes 1 and 2 to the
consolidated financial statements.
In our opinion, these supplemental financial statement schedules, when
considered in relation to the basic financial statements taken as a whole,
present fairly, in all material aspects, the information required to be included
therein.
We previously audited and reported on the financial statements and
financial statement schedules of Medisys, Inc. and Subsidiaries as of December
31, 1991 and for the year then ended, prior to their restatement for the 1993
pooling of interests. The contribution of Medisys, Inc. and Subsidiaries to
total revenues and net income represented 67 and 42 percent of the respective
restated totals. Separate financial statements and financial statement schedules
of American Home Therapies included in the statements and schedules referred to
above were audited and reported on separately by other auditors. We have also
audited the combination of the accompanying financial statement schedules as of
December 31, 1991 and for the year then ended, after restatement for the 1993
pooling of interests; in our opinion, such supplemental financial statement
schedules have been properly combined on the basis described in Note 1 of the
notes to the consolidated financial statements.
COOPERS & LYBRAND
Minneapolis, Minnesota
February 11, 1994
S-10
<PAGE> 15
SCHEDULE VIII
MEDISYS, INC. AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
FOR THE YEARS ENDED DECEMBER 31, 1991, 1992 AND 1993
<TABLE>
<CAPTION>
ADDITIONS
------------------------
BALANCE AT CHARGED CHARGED
BEGINNING TO COSTS TO OTHER BALANCE
OF AND ACCOUNTS-- DEDUCTIONS-- AT END OF
PERIOD EXPENSES DESCRIBE DESCRIBE PERIOD
---------- ---------- --------- ----------- ----------
<S> <C> <C> <C> <C> <C>
Allowance for doubtful accounts
1991......................... $ 82,543 $ 225,790 $ 27,843(1) $ 280,490
1992......................... 280,490 597,726 $434,886 (2) 345,168(1) 967,934
1993......................... 967,934 1,013,850 791,920(1) 1,189,864
</TABLE>
- ---------------
(1) Write-off of trade accounts receivable, net of bad debt recoveries.
(2) Allowances for doubtful accounts acquired through business combinations.
S-11
<PAGE> 16
SCHEDULE IX
MEDISYS, INC. AND SUBSIDIARIES
SHORT-TERM BORROWINGS
FOR THE YEARS ENDED DECEMBER 31, 1991, 1992, AND 1993
<TABLE>
<CAPTION>
AVERAGE
WEIGHTED INTEREST
CATEGORY OF BALANCE AVERAGE MAXIMUM AVERAGE RATE
AGGREGATE SHORT AT END INTEREST AMOUNT AMOUNT DURING
TERM BORROWINGS(1) OF PERIOD RATE OUTSTANDING OUTSTANDING PERIOD(2)
- --------------------------------- ---------- -------- ----------- ----------- ---------
<S> <C> <C> <C> <C> <C>
1993
Notes payable to banks for
borrowings..................... $4,950,000 6.75% $ 4,950,000 $ 2,425,000 6.75%
1992
Notes payable to banks for
borrowings..................... 500,000 12.0% 500,000 42,000 12.0%
1991
Notes payable to banks for
borrowings..................... 325,000 8.0% 1,300,900 1,056,000 11.0%
</TABLE>
- ---------------
(1) See Note 3 of Notes to Consolidated Financial Statements for descriptions of
borrowing arrangements.
(2) Weighted average interest rate during the period is calculated by dividing
interest expense, including fees paid to factor, by the average amount
outstanding based on month-end balances.
S-12
<PAGE> 17
SCHEDULE X
MEDISYS, INC. AND SUBSIDIARIES
SUPPLEMENTARY INCOME STATEMENT INFORMATION
FOR THE YEARS ENDED DECEMBER 31, 1991, 1992 AND 1993
<TABLE>
<CAPTION>
1991 1992 1993
-------- -------- ----------
<S> <C> <C> <C>
Maintenance and repairs................................... -- -- --
Depreciation and amortization of intangibles.............. -- -- --
Taxes other than payroll and income....................... -- -- --
Rents..................................................... $444,804 $848,764 $1,347,880
Advertising costs......................................... -- -- --
</TABLE>
S-13
<PAGE> 18
EXHIBIT INDEX
<TABLE>
<CAPTION>
SEQUENTIALLY
EXHIBIT NUMBERED
NO. DESCRIPTION PAGE
------- -------------------------------------------------------------------- ------------
<C> <S> <C>
23.4 Consent of Arthur Andersen & Co.....................................
</TABLE>
<PAGE> 1
EXHIBIT 23.4 TO
REGISTRATION STATEMENT
ON FORM S-4
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
As independent certified public accountants, we hereby consent to the use
of our reports with respect to the consolidated financial statements and
schedules of HealthInfusion, Inc. and subsidiaries and tax opinion dated June 6,
1994, included in, or made a part of, this Form S-4 Registration Statement of
Coram Healthcare Corporation.
/s/ ARTHUR ANDERSEN & CO.
Arthur Andersen & Co.
Miami, Florida
June 6, 1994
